Q3 FY26 Quarterly Activities Report (App 4C)
Filed with ASX ·
6ix is reading this filing.
Hydration Pharmaceuticals Company Limited on 6ix
Earlier from Hydration Pharmaceuticals
- Prospectus - Non Renounceable Rights Issue
- Rights Issue and UMP Share Sale Facility
- July and August 2026 Trading Update
- Appendix 4D and FY26 Half Year Financial Report
- Q2 FY26 Quarterly Activities Report (App 4C)
Follow Hydration Pharmaceuticals into a list and get an email when it puts out news.
Follow Hydration Pharmaceuticals